Gates Foundation partners with Indian drugmakers to speed rollout of $40 HIV shot
via theconversation.com
Short excerpt below. Read at the original source.
A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people, with new generic versions priced at about $40 per patient per year. The Gates Foundation and Indian drugmaker Hetero Labs Ltd. are among the groups moving to produce the medication, lenacapavir, which Gilead Sciences Inc. sells in […]